Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
评价ZG-001在中国健康受试者中单次递增、多次递增口服给药的安全性、耐受性、药代动力学特征及食物对药代动力学影响的临床研究
[Translation] Clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and the impact of food on pharmacokinetics of ZG-001 in single-incremental and multiple-incremental oral administration in Chinese healthy subjects
研究健康受试者单次口服不同剂量ZG-001胶囊的耐受性及药代动力学,研究健康受试者多次口服不同剂量ZG-001胶囊的耐受性及药代动力学,研究饮食对健康受试者口服ZG-001胶囊药代动力学的影响,为后期临床试验提供依据。
[Translation] Study the tolerance and pharmacokinetics of ZG-001 capsules in healthy subjects after a single oral administration of different doses. Study the tolerance and pharmacokinetics of ZG-001 capsules in healthy subjects after multiple oral administrations of different doses. Study the diet. The effect on the pharmacokinetics of ZG-001 capsules taken orally by healthy subjects will provide a basis for later clinical trials.
100 Clinical Results associated with Shanghai Zhigen Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Shanghai Zhigen Pharmaceutical Technology Co., Ltd.
100 Deals associated with Shanghai Zhigen Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Shanghai Zhigen Pharmaceutical Technology Co., Ltd.